ScholarWorks@Gachon

Detailed Information

Cited 2 time in webofscience Cited 3 time in scopus
Metadata Downloads

Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma (R)) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+metastatic breast cancer (KCSG BR 18-14/KM10B)

Full metadata record
DC Field Value Language
dc.contributor.authorSim, Sung Hoon-
dc.contributor.authorKim, Jeong Eun-
dc.contributor.authorKim, Min Hwan-
dc.contributor.authorPark, Yeon Hee-
dc.contributor.authorKim, Jee Hyun-
dc.contributor.authorSuh, Koung Jin-
dc.contributor.authorKoh, Su-Jin-
dc.contributor.authorPark, Kyong Hwa-
dc.contributor.authorKang, Myoung Joo-
dc.contributor.authorAhn, Mi Sun-
dc.contributor.authorLee, Kyoung Eun-
dc.contributor.authorKim, Hee -Jun-
dc.contributor.authorAhn, Hee Kyung-
dc.contributor.authorKim, Han Jo-
dc.contributor.authorPark, Keon Uk-
dc.contributor.authorByun, Jae Ho-
dc.contributor.authorPark, Jin Hyun-
dc.contributor.authorLee, Gyeong-Won-
dc.contributor.authorLee, Keun Seok-
dc.contributor.authorSohn, Joohyuk-
dc.contributor.authorJung, Kyung Hae-
dc.contributor.authorPark, In Hae-
dc.date.accessioned2022-10-07T02:40:11Z-
dc.date.available2022-10-07T02:40:11Z-
dc.date.created2022-09-22-
dc.date.issued2022-10-
dc.identifier.issn0960-9776-
dc.identifier.urihttps://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/85632-
dc.description.abstractWe investigated the efficacy and safety of a trastuzumab biosimilar, Herzuma (R), in combination with treatment of physician's choice (TPC) in patients with HER2+ metastatic breast cancer (MBC) who had failed at least two HER2 directed chemotherapies.-
dc.language영어-
dc.language.isoen-
dc.publisherCHURCHILL LIVINGSTONE-
dc.relation.isPartOfBREAST-
dc.titlePhase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma (R)) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+metastatic breast cancer (KCSG BR 18-14/KM10B)-
dc.typeArticle-
dc.type.rimsART-
dc.description.journalClass1-
dc.identifier.wosid000854087700004-
dc.identifier.doi10.1016/j.breast.2022.08.002-
dc.identifier.bibliographicCitationBREAST, v.65, pp.172 - 178-
dc.description.isOpenAccessY-
dc.identifier.scopusid2-s2.0-85136302494-
dc.citation.endPage178-
dc.citation.startPage172-
dc.citation.titleBREAST-
dc.citation.volume65-
dc.contributor.affiliatedAuthorAhn, Hee Kyung-
dc.type.docTypeArticle-
dc.subject.keywordAuthorHER2 positive-
dc.subject.keywordAuthorMetastatic breast cancer-
dc.subject.keywordAuthorTrastuzumab biosimilar-
dc.subject.keywordAuthorClinical trial-
dc.subject.keywordAuthorctDNA-
dc.subject.keywordPlusDOUBLE-BLIND-
dc.subject.keywordPlusPROGRESSION-
dc.subject.keywordPlusRETREATMENT-
dc.subject.keywordPlusGUIDELINE-
dc.subject.keywordPlusMUTATIONS-
dc.subject.keywordPlusEMTANSINE-
dc.subject.keywordPlusLAPATINIB-
dc.subject.keywordPlusHER2-
dc.relation.journalResearchAreaOncology-
dc.relation.journalResearchAreaObstetrics & Gynecology-
dc.relation.journalWebOfScienceCategoryOncology-
dc.relation.journalWebOfScienceCategoryObstetrics & Gynecology-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
Files in This Item
There are no files associated with this item.
Appears in
Collections
의과대학 > 의학과 > 1. Journal Articles
Show simple item record

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Ahn, Hee Kyung photo

Ahn, Hee Kyung
College of Medicine (Department of Medicine)
Read more

Altmetrics

Total Views & Downloads

STATISTICS
Total View :4,146,697
Today View :7,680

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114

COPYRIGHT 2020 Gachon University All Rights Reserved.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어